InsiderClue
Insiders · Profile

Shannon James Samuel

Director at Xilio Therapeutics. Filing since 16 Jun 2025. CIK 0001485417

Company
Date
Role
Action
Shares
Amount
Of holding
XLO Xilio Therapeutics, Inc.
26 Mar 2026
Director
Bought
5,000
$43.95K
100%
XLO Xilio Therapeutics, Inc.
17 Jun 2025
Director
Bought
25,000
$17.22K
55.6%
XLO Xilio Therapeutics, Inc.
16 Jun 2025
Director
Bought
45,000
$30.87K
opened
3 decisions on file.